112.19 USD
↗ 1.43 (1.29%)LIVE (AS OF 12:41 PM EDT)
Dianthus Therapeutics, Inc. Common Stock
DNTHNASDAQ • USD
Market: OPEN
Dianthus Therapeutics, Inc. Common Stock (DNTH) trades at $112.19 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$111.28
High?$122.56
Low?$106.03
Prev. Close?$110.76
Volume?108.7K
Avg. Volume?763.0K
VWAP?$111.26
Rel. Volume?0.14x
Bid / Ask
Bid?$94.94 × 100
Ask?$127.86 × 100
Spread?$32.92
Midpoint?$111.40
Valuation & Ratios
Market Cap?6.2B
Shares Out?54.7M
Float?51.2M
Float %?93.7%
P/E Ratio?N/A
P/B Ratio?5.29
EPS?-$3.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Employees
92
Market Cap
6.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-09-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: 929-999-4055
NEW YORK, NY 10036
Phone: 929-999-4055
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?100
Momentum?48
Short Sent.?39
Piotroski F-Score?2/9Weak
Altman Z-Score?89.89Safe
Confidence?55%Low
Short InterestVery High
Short % of Float?16.44%High
Short Interest?8.4M
Days to Cover?11.5
Free Float51.2M
Avg Daily Volume729.4K
Settlement Date2026-08-14
Financial Health
Current Ratio?26.10Strong
Quick Ratio?26.10Strong
Cash Ratio?3.21Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?5.29FAIR▾
Peers100
S&P35
P/S?3,253.83HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-28.0CHEAP▾
S&P97
EV/Sales?3,195.77HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-16.4%WEAK▾
S&P8
ROA?-15.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-155709000
Enterprise Value?$6.1B
Fundamentals ratios updated end of day